Tecan Group AG
TCHBF
Other OTC211.03
USD
+34.03
- -
ISIN
CH0012100191
Return %
Stock
S&P500
1Y
10.42
26.84
3Y
-47.06
77.03
5Y
-56.93
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Monica Manotas
- Full Time Employees
- 3,074
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- Seestrasse 103 Männedorf Switzerland 8708
- IPO Date
- Apr 1, 2013
- Website
- tecan.com
- Similar Companies
- Business
- Tecan Group AG (TCHBF) develops, manufactures, and distributes automated laboratory instruments, workflow solutions, and components primarily for life sciences research, clinical diagnostics, forensics, biopharmaceuticals, and applied markets. The company operates through two main segments: Life Sciences Business, which supplies end users with laboratory automation platforms, liquid handling and robotics systems, microplate readers and washers, microarray products, sample management tools including the HP D300 Digital Dispenser, consumables such as disposable tips, reagent troughs, and microplates, next-generation sequencing (NGS) reagents, immunoassays for infectious diseases, autoimmunity, neurodegeneration, endocrinology, and food intolerance, software packages, and related services; and Partnering Business, which provides original equipment manufacturing (OEM) solutions including Synergence platforms, Cavro components, Paramit contract development and manufacturing services for medical devices, precision machining via Tecan DCPM, and custom instrumentation for laboratory diagnostics, Medtech, and life sciences. Products also encompass specialized offerings like FluentControl software for assay development, Veya and Duo liquid handling instruments, Resolvex for sample preparation in genomics and chromatography, MagicPrep NGS system, and ELISA kits for specialty diagnostics. Tecan serves pharmaceutical and biotechnology firms, university research departments, diagnostic laboratories, and OEM partners, with a majority of revenue from the Americas and Europe, and maintains manufacturing, R&D, and sales operations across Europe, North America, Asia, and over 70 countries. Founded in 1980 and headquartered in Männedorf, Switzerland, the company employs over 3,000 people. Recent developments include the acquisition of assets from Wako Automation on December 1, 2025, adding the Director scheduling software and robotic workcell hardware to expand automation capabilities; purchase of ELISA immunoassay assets from Cisbio Bioassays (a Revvity subsidiary) in April 2025, incorporating two in vitro diagnostic and two research-use-only kits to bolster specialty diagnostics; a partnership with Grifols announced in 2025 for biomarker panels using single molecule counting technology; new manufacturing contracts through Paramit and Synergence with global diagnostics and life sciences customers for commercial systems; and enriched project pipelines via joint selling of Synergence, Cavro, and Paramit offerings targeting lab diagnostics and Medtech, alongside a goal to double new project signings by 2027.
Tecan to create Data-Driven Labs with NVIDIA
Tecan Group AG (TCGGY) Analyst/Investor Day Transcript
Tecan Group AG (TCGGY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q's Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control
Tecan Group AG (TCHBF) Q2 2025 Earnings Call Transcript
Tecan Group AG (TCHBF) Q4 2024 Earnings Call Transcript
Tecan Group AG (TCHBF) Q2 2024 Earnings Call Transcript
Tecan appoints Mukta Acharya Head of the Life Sciences Business division
Tecan Group AG (TCHBF) Q4 2023 Earnings Call Transcript
Tecan Group AG (TCHBF) Q2 2023 Earnings Call Transcript